Profound Medical Corp. announced the signing of its first-ever U.S. multi-site imaging center agreement for TULSA-PRO with RadNet Inc. TULSA-PRO® is a transurethral prostate tissue ablation system that combines real-time MRI with robotically-driven directional thermal ultrasound and closed-loop temperature feedback control software to deliver predictable physician prescribed ablation of whole-gland or partial prostate tissue. The TULSA-PRO system is designed to provide customizable and predictable, incision-free and radiation-free prostate ablation while actively protecting the urethra and rectum with water cooling to preserve men's functional abilities. Pursuant to the agreement, Profound will install TULSA-PRO systems at three RadNet imaging centers in the greater Los Angeles area, with one such installation anticipated in each of first quarter, second quarter and third quarter of 2020. Profound will rent the systems to RadNet on a per-use basis, in addition to selling it per-use consumables. Based upon the success of these installations, the two companies hope to expand their partnership in the future to include additional RadNet centers in other U.S. markets.